Leave Your Message
Explore our premium product range designed for pharmaceutical-grade applications and advanced healthcare formulations.
Understanding the science behind one of the most versatile pharmaceutical and healthcare ingredients in the modern biotech era.
🔬 Collagen Peptides Powder is produced through the enzymatic hydrolysis of native collagen proteins — primarily sourced from bovine, marine, or porcine origins — resulting in short-chain bioactive peptides with molecular weights typically ranging from 1,000 to 5,000 Daltons. This low molecular weight ensures superior gastrointestinal absorption, rapid bioavailability, and targeted tissue delivery, making it the gold-standard ingredient for pharmaceutical and healthcare product development.
Enzymatic hydrolysis technology produces peptides with controlled molecular weight distribution (1–5 kDa), ensuring consistent bioavailability and reproducible clinical outcomes in pharmaceutical formulations.
Our collagen peptides powder undergoes multi-stage purification, heavy metal testing, microbiological screening, and HPLC verification to meet USP/EP pharmaceutical ingredient standards.
Available in bovine-derived (Type I & III), marine-derived (fish collagen), and halal/kosher-certified variants to meet the specific regulatory and formulation needs of global healthcare markets.
The collagen peptides market is experiencing unprecedented growth, driven by aging populations, expanding pharmaceutical pipelines, and rising consumer health awareness worldwide.
The global collagen market was valued at over USD 9.8 billion in 2023 and is projected to surpass USD 19.5 billion by 2032, growing at a CAGR of approximately 8.6%. The pharmaceutical and nutraceutical segments are the fastest-growing application areas, fueled by clinical evidence supporting collagen's efficacy in joint health, wound healing, and bone regeneration.
Modern collagen peptide manufacturers are investing heavily in enzymatic hydrolysis technology, continuous extraction systems, and AI-driven quality control platforms. The shift from batch processing to continuous manufacturing is reducing production costs by up to 30%, enabling more competitive pharmaceutical-grade pricing without compromising purity standards.
North America and Europe dominate pharmaceutical-grade collagen demand, while Asia-Pacific — particularly China, Japan, and South Korea — leads in nutraceutical and cosmeceutical applications. Emerging markets in Latin America and the Middle East are showing 12%+ annual growth rates, creating new B2B opportunities for certified collagen peptide suppliers.
Collagen peptides powder serves as a critical active ingredient and functional excipient across a broad spectrum of pharmaceutical and healthcare product categories.
Collagen peptides — particularly Type II collagen hydrolysate — are formulated into prescription-grade tablets, capsules, and injectable solutions for osteoarthritis management and cartilage regeneration. Clinical studies demonstrate that 10g/day supplementation significantly reduces joint pain scores and improves mobility within 12 weeks. Pharmaceutical manufacturers increasingly incorporate collagen peptides as active pharmaceutical ingredients (APIs) in combination therapies with glucosamine and chondroitin.
Medical-grade collagen peptide matrices are used in advanced wound dressings, hemostatic agents, and dermal fillers. Collagen's inherent biocompatibility and ability to stimulate fibroblast proliferation make it indispensable in burn treatment, chronic wound management, and post-surgical tissue repair. The global wound care collagen market segment is projected to grow at 9.2% CAGR through 2030.
Collagen peptides serve as biodegradable scaffolds and drug delivery matrices in cutting-edge pharmaceutical research. Their ability to form hydrogels, microspheres, and nanoparticles at physiological pH enables controlled-release formulations for oncology drugs, antibiotics, and growth factors. This application segment is attracting significant R&D investment from major pharmaceutical corporations globally.
Hydrolyzed collagen peptides are formulated into medical nutrition products for patients with sarcopenia, post-surgical recovery needs, and malnutrition conditions. Their high digestibility (>95%), complete amino acid profile rich in glycine, proline, and hydroxyproline, and neutral flavor make them ideal for tube-feeding formulas, oral nutritional supplements (ONS), and hospital-grade protein powders.
The convergence of pharmaceutical and cosmetic science has created a booming cosmeceutical segment where collagen peptides are formulated into prescription-strength anti-aging serums, injectable skincare treatments, and evidence-based oral beauty supplements. Marine collagen peptides with low molecular weight (<1000 Da) demonstrate superior dermal penetration and have shown statistically significant improvements in skin elasticity and hydration in double-blind clinical trials.
Sports medicine applications represent one of the fastest-growing segments for pharmaceutical-grade collagen peptides. Formulations targeting tendon repair, ligament strengthening, and muscle recovery are being developed in collaboration with sports medicine clinics and professional athletic organizations. Collagen peptides combined with Vitamin C have demonstrated accelerated tendon collagen synthesis in multiple randomized controlled trials.
Innovation and regulatory evolution are redefining how collagen peptides are developed, validated, and commercialized in pharmaceutical and healthcare markets.
Next-generation collagen peptides produced via yeast and bacterial fermentation platforms are entering pharmaceutical pipelines, offering animal-free, pathogen-free alternatives with precisely defined peptide sequences. This technology is expected to capture 15% of the pharmaceutical collagen market by 2030.
Artificial intelligence and machine learning algorithms are being deployed to optimize collagen peptide molecular weight distribution, solubility profiles, and bioavailability predictions — dramatically accelerating pharmaceutical product development timelines from years to months.
The convergence of genomics, microbiome science, and collagen peptide research is enabling personalized healthcare formulations tailored to individual genetic profiles and health conditions. Pharmacogenomic-guided collagen supplementation protocols are being validated in clinical settings.
Pharmaceutical-grade collagen manufacturers are adopting zero-waste extraction processes that valorize marine and livestock by-products. Blue economy initiatives and upcycled collagen from fish skin and scales are gaining regulatory acceptance in EU and US pharmaceutical markets.
Global regulatory bodies including FDA, EMA, and NMPA are developing clearer frameworks for collagen peptide health claims, pushing manufacturers toward robust clinical trial programs. Companies investing in randomized controlled trials are gaining significant competitive advantages in premium pharmaceutical markets.
Advanced nano-encapsulation and liposomal delivery systems are enhancing the stability, bioavailability, and targeted delivery of collagen peptides in pharmaceutical formulations — opening new therapeutic application windows in oncology support, inflammatory disease management, and regenerative medicine.
From raw pharmaceutical ingredients to finished dosage forms — YTBIO delivers complete collagen peptide solutions for global healthcare brands.
Nutritional supplement raw materials — including collagen peptides powder, amino acid complexes, and botanical co-factors — are primarily used in pharmaceutical and healthcare product manufacturing to supplement essential proteins, trace elements, vitamins, and minerals required by the human body.
YTBIO has over ten years of experience in the pharmaceutical raw materials industry, with deep expertise in collagen peptide specification development, regulatory documentation, and custom formulation services. We support full OEM/ODM services and are committed to providing reliable, clinically validated health ingredient solutions to global pharmaceutical and healthcare customers.
Explore OEM Services
Our collagen capsule range includes hard capsules, soft gel capsules, and pellet capsules — all manufactured under strict GMP conditions. Collagen peptide capsules are among the most popular pharmaceutical delivery formats due to their precise dosing, excellent patient compliance, and extended shelf stability.
Full customization is available: collagen source selection (bovine, marine, porcine), peptide molecular weight specification, co-ingredient formulation (Vitamin C, Hyaluronic Acid, Biotin), packaging design, label artwork, and private label branding. Multiple validated formulas and ready-to-order stock are available for accelerated market entry.
View Capsule Products
Our tablet manufacturing capabilities include fluid-bed granulation, direct compression, film coating, and enteric coating technologies — enabling collagen peptide tablets with optimized dissolution profiles for pharmaceutical-grade bioavailability. Production materials meet national and international pharmacopeial standards, with comprehensive in-process quality controls at every manufacturing stage.
Customization options include collagen peptide concentration, tablet shape and embossing, film coating color and functionality, packaging format (blister, bottle, sachet), and complete label and branding customization. Extensive validated formulas and stock inventory are available for rapid commercial deployment.
View Tablet ProductsA decade of pharmaceutical-grade manufacturing excellence, serving global healthcare brands with science-backed collagen ingredient solutions.
Since its establishment in 2014, Shaanxi Yuantai Biological Technology Co., Ltd. has always focused on the research, development, production and sales of herbal extracts, nutritional supplements, organic products and OEM/ODM services. With high standards of product quality and a professional team as the core, the company provides customers with high-quality health product solutions — including pharmaceutical-grade collagen peptides powder for global healthcare markets. We always adhere to the concept of sustainability, balance and health to ensure that our products meet market demand and consumer expectations.
All YTBIO collagen peptide products are produced in-house across a 10,000+ ㎡ GMP-certified facility, equipped with advanced enzymatic hydrolysis systems, spray drying towers, and dedicated pharmaceutical-grade processing areas for capsules, granules, tablets, and solid beverage formats.
Production facilities meet national and international standards. Every batch of collagen peptides powder undergoes rigorous QA/QC protocols including molecular weight distribution analysis, heavy metal testing, microbiological assays, and HPLC purity verification — strictly in accordance with GMP requirements.
Our comprehensive certification portfolio includes: cGMP, FSSC22000, BRC, HACCP, ISO9001, ISO22000, HALAL, KOSHER, FDA registration, and organic certifications — providing full regulatory compliance documentation for pharmaceutical and healthcare customers across all major global markets.
Looking for pharmaceutical-grade collagen peptides powder with competitive pricing and reliable supply? Our team provides customized quotations, technical specifications, and regulatory documentation for B2B pharmaceutical and healthcare clients worldwide.
Provide customers with quality products.
For product information and quotes, contact us!
99%
80 Mesh, 200 Mesh
30g, 50g
180 pcs/bag
60 PCS/Bottle
120 PCS/Bottle
120 Capsules/Bottle
60 PCS/Bottle
YTBIO covers an area of 10,000+㎡ and has passed cGMP, FSSC22000, BRC, ISO9001, ISO22000, KOSHER, HALAL, FDA, and organic certifications. The production process is strictly carried out in accordance with scientific production standards to ensure the safety, stability and effectiveness of all collagen peptide products. A modern quality management system covering raw material inspection, in-process monitoring, and finished product testing ensures every batch meets pharmaceutical-grade specifications.
Trusted by pharmaceutical and healthcare brands worldwide through internationally recognized quality certifications.
Comprehensive pharmaceutical and nutraceutical raw material solutions from YTBIO's extensive product portfolio.
